Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:II_170

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Zuba-Surma, E. K
Right arrow Articles by Dawn, B.
PubMed
Right arrow Articles by Zuba-Surma, E. K
Right arrow Articles by Dawn, B.

(Circulation. 2006;114:II_170.)
© 2006 American Heart Association, Inc.


Stem Cell Therapy for the Failing Heart

Abstract 937: Antigenically-Defined Subsets of Bone Marrow Mesenchymal Stem Cells Exhibit Differential Cardiomyogenic and Angiogenic Potential

Ewa K Zuba-Surma; Ahmed Abdel-Latif; Robert J Vincent; Smita Ranjan; Sumit Tiwari; Mamdouh Khayat; Roberto Bolli; Buddhadeb Dawn

Univ Of Louisville, Louisville, KY

Bone marrow mesenchymal stem cells (BMMSCs) are typically isolated as adherent cells; the importance of antigen expression on cardiomyogenic potential of (BMMSCs) remains unclear. Although BMMSCs differentiate into a cardiomyocytic phenotype following 5-azacytidine treatment, the effect of non-toxic growth factors on differentiation induction remains unknown. We investigated the cardiomyogenic potential of two subpopulations of BMMSCs in medium containing growth factors crucial for cardiac development. Sca-1+/CD45-/c-kit-/Thy1+/ CD105+ (BMMSC+) and Sca-1+/CD45-/c-kit-/Thy1+/CD105- (BMMSC-) MSCs were obtained from the adherent fraction of BM from C57BL/6 mice using two-step FACS isolation. Cells were differentiated in DMEM with FBS, IGF-1, Dynorphin B, TGFß-1 and FGF-2. After 30 days of culture, the expression of cardiac-specific transcription factors (TFs) and intracellular antigens (IAs) was quantitatively evaluated by confocal microscopy (Fig. 1A). BMMSC- cells exhibited greater cardiac differentiation potential compared with BMMSC+ and unfractionated BMMSC populations (29.1±1.7% vs. 15.7±1.6% vs. 15.8±0.9% of cells positive for cardiac markers, Fig. 1B). BMMSC- cells also exhibited greater angiogenic potential assessed by tube formation after 6 h of culture in Matrigel (Fig. 1C) when compared with BMMSC± and unfractionated BMMSC populations (364±11.4 vs. 268±14.4 vs. 293.7±33.6 of endotubules per field, Fig. 1D). These results indicate that selected non-toxic growth factors can effectively induce cardiac differentiation of BMMSCs and that BMMSCs lacking CD105 expression have greater proclivity to cardiac and endothelial differentiation.


Figure 1





This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Zuba-Surma, E. K
Right arrow Articles by Dawn, B.
PubMed
Right arrow Articles by Zuba-Surma, E. K
Right arrow Articles by Dawn, B.